<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN" "http://www.w3.org/TR/REC-html40/loose.dtd">
<html><body><html><body><section class="summaryOfFindings"><div class="section-header section-collapse-header" id="CD004624-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"><div class="section-header" id="CD004624-sec1-0001"></div> <div class="table" id="CD004624-tbl-0001"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings for the main comparison.</span>Â <span class="table-title">Ibuprofen versus paracetamol for pain relief following the surgical removal of lower wisdom teeth</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Ibuprofen versus paracetamol for pain relief following the surgical removal of lower wisdom teeth</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Patients with pain after surgical removal of lower wisdom teeth<br><b>Intervention:</b> Ibuprofen </p> <p><b>Control:</b> Paracetamol </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed<sup>1</sup> risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Control</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Ibuprofen </b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Proportion of patients with &gt; 50% maximum pain relief (TOTPAR) over 6 hours â Ibuprofen 400 mg versus paracetamol 1000 mg</b> <br> Categorical scale<br> Followâup: 6 hours </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Study population</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.47</b> <br> (1.28 to 1.69) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>646<br> (5 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>high</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>When all doses considered RR = 1.45 (95% CI 1.31 to 1.61) (6 studies, 926 participants; high quality evidence) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>56 per 100</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>83 per 100</b> <br> (72 to 95) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Proportion of patients with &gt; 50% maximum pain relief (TOTPAR) over 2 hours â Ibuprofen 400 mg versus paracetamol 1000 mg</b> <br> Categorical scale<br> Followâup: 2 hours </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Study population</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.30</b> <br> (1.09 to 1.55) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>645<br> (5 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>high</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>When all doses considered RR = 1.29 (95% CI 1.13 to 1.46) (6 studies, 926 participants; high quality evidence) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>62 per 100</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>81 per 100</b> <br> (68 to 97) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Number of patients not using rescue medication at 6 hours (<i>nonâevent</i>)</b> <br><b>â Ibuprofen 400 mg versus paracetamol 1000 mg</b> </p> <p>Followâup: 6 hours</p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Study population</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.50</b> <br> (1.25 to 1.79) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>542<br> (4 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>high</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>When all doses considered RR = 1.44 (95% CI 1.13 to 1.64) (5 studies, 823 participants; high quality evidence) </p> </td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>50 per 100</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>75 per 100</b> <br> (63 to 90) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>The majority of adverse events were minor in nature and usually included nausea, vomiting, headaches and dizziness. </p> <p>Side effect profiles have not been included in a metaâanalysis as multiple adverse events were recorded in single patients. However, the differences in the observed adverse events for ibuprofen and paracetamol were small </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> This is the median control group risk based on paracetamol being the control group. </p> </div> </td> </tr></tfoot>
</table>
</div> <div class="table" id="CD004624-tbl-0002"> <a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading">
<span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Combined (ibuprofen and paracetamol) versus single drugs for pain relief after surgical removal of lower wisdom teeth</span>
</div>
<table class="summary-of-findings framed">
<tbody>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Combined (ibuprofen and paracetamol) versus single drugs for pain relief after surgical removal of lower wisdom teeth</b> </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p><b>Patient or population:</b> Patients with pain after surgical removal of lower wisdom teeth<br><b>Intervention:</b> Combined (ibuprofen and paracetamol) versus single drugs </p> <p><b>Control:</b> Single drugs </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Outcomes</b> </p> </td> <td align="left" valign="top" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Relative effect<br> (95% CI)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>No of participants<br> (studies)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Quality of the evidence<br> (GRADE)</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="3" class="table-header"> <p><b>Comments</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Assumed<sup>1</sup> risk</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>Corresponding risk</b> </p> </td> </tr>
<tr class="table-header separated">
<td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Control</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b> Combined (ibuprofen and paracetamol) </b> </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Proportion of patients with &gt; 50% maximum pain relief (TOTPAR) over 6 hours â Paracetamol 1000 mg/ibuprofen 400 mg versus paracetamol 1000 mg or ibuprofen 400 mg</b> <br> Categorical scale<br> Followâup: 6 hours </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Study population</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.77</b> <br> (1.32 to 2.39) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>170<br> (1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>moderate<sup>2</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>38 per 100</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>67 per 100</b> <br> (50 to 91) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Proportion of patients with &gt; 50% maximum pain relief (TOTPAR) over 2 hours â Paracetamol 1000 mg/ibuprofen 400 mg versus paracetamol 1000 mg or ibuprofen 400 mg</b> <br> Categorical scale<br> Followâup: 2 hours </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Study population</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.29</b> <br> (0.91 to 1.85) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>170<br> (1 study) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>moderate<sup>2</sup></b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>37 per 100</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>48 per 100</b> <br> (34 to 68) </p> </td> </tr>
<tr class="separated">
<td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>Number of patients not using rescue medication at 8 hours â Paracetamol 1000 mg/ibuprofen 400 mg versus paracetamol 1000 mg or ibuprofen 400 mg</b> <br> Followâup: 8 hours </p> </td> <td align="" valign="" colspan="2" rowspan="1" class="table-tint table-highlight"> <p><b>Study population</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p><b>RR 1.60</b> <br> (1.36 to 1.88) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>467<br> (2 studies) </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"> <p>ââââ<br><b>high</b> </p> </td> <td align="left" valign="top" colspan="1" rowspan="2" bgcolor="#ffffff"></td> </tr>
<tr class="separated">
<td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>50 per 100</b> </p> </td> <td align="" valign="top" colspan="1" rowspan="1" class="table-tint table-highlight"> <p><b>80 per 100</b> <br> (68 to 94) </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Adverse events</b> </p> </td> <td align="" valign="" colspan="6" rowspan="1" class="table-tint table-highlight"> <p>The majority of adverse events were minor in nature and usually included nausea, vomiting, headaches and dizziness. Side effect profiles have not been included in a metaâanalysis as multiple adverse events were recorded in single patients. However, the differences in the observed adverse events for ibuprofen and paracetamol were small </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br><b>CI:</b> confidence interval; <b>RR:</b> risk ratio. </p> </td> </tr>
<tr class="separated">
<td align="" valign="" colspan="7" rowspan="1" bgcolor="#ffffff"> <p>GRADE Working Group grades of evidence<br><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr>
</tbody>
<tfoot><tr>
<td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> This is the median control group risk based on paracetamol/ibuprofen as single drugs being the control group. </p> <p><sup>2</sup> Quality of evidence downgraded due to single study and serious imprecision. </p> </div> </td> </tr></tfoot>
</table>
</div> </section></section></body></html></body></html>
